Picture of Intra-Cellular Therapies logo

ITCI — Intra-Cellular Therapies News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Intra-Cellular Therapies Q1 net loss USD 44.1 million

May 4 (Reuters) - Intra-Cellular Therapies Q1 net income USD -44.1 million.
* Q1 product revenue USD 95.3 million
* Outlook FY product revenue USD 430-455 million

Recent news on Intra-Cellular Therapies

See all news